ed

NATIONAL INSTITUTES OF HEALTH

National Institute of Child Health and Human Development

NIH NEWS RELEASE

EMBARGOED FOR RELEASE

Friday, November 29, 2002

12:01 a.m. ET

Contact: Robert Bock or Marianne Glass Duffy

(301) 496-5133

STUDY CONFIRMS BREAST CANCER RISK IN CONTINUOUS COMBINED HORMONE THERAPY RISK BEGINS TO RETURN TO NORMAL AFTER WOMEN STOP TAKING HORMONES


FDA Talk Papers are prepared by the Press Office to guide FDA personnel in responding with consistency and accuracy to questions from the public on subjects of current interest. Talk Papers are subject to change as more information becomes available.

T02-50

Media Inquiries: 301-827-6242

November 26, 2002

Consumer Inquiries: 888-INFO-FDA


ng Click here

rs

From: News, FDA

Sent: Wednesday, November 27, 2002 11:50 AM

To: FDA-Wide Metro

Subject: Appointment of Assistant Commissioner for Regulatory Affairs


FOR IMMEDIATE RELEASE

P02-51

November 27, 2002

Media Inquiries: 301-827-6242

Consumer Inquiries: 888-INFO-FDA

FDA has approved Claritin (loratadine) as an over-the-counter (OTC) allergy drug product. Previously available only as a prescription drug, Claritin is approved for seasonal allergic rhinitis -- a condition that causes runny nose, nasal congestion, sneezing, and itchy nose, throat, eyes, and ears.


FOR IMMEDIATE RELEASE

CONTACT: Sherrie Borden

301/816-8268; slb@usp.org


/index.php?option=com_iwpfile&file=/dir_01/he2002_2950.pdf

em

The state of California and Los Angeles County Board of Supervisors have filed a new Medicaid waiver application with CMS in a bid to bolster Los Angeles' fiscally troubled health care system. The four-pronged waiver request was submitted Nov. 27. Click here for Press Release On California Waiver


ge

For Release: Immediately

Contact: CMS Press Office, 202-690-6145

HHS TO HELP STATES CREATE HIGH-RISK POOLS TO INCREASE ACCESS TO HEALTH COVERAGE

HHS Secretary Tommy G. Thompson today announced a new program to help states create high-risk pools that will provide health coverage to individuals who otherwise would have difficulty obtaining coverage because of their health status.


/index.php?option=com_iwpfile&file=/dir_01/he2002_2947.pdf

Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.